The real reason drug costs are so high in America
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
Oncology Leaders Blast “Ridiculous” Proposed Cuts to Physician Fees
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
Change Healthcare cyberhack fallout ripples to consumers
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
The effort to reform physician pay is set to pit primary care docs against highly paid specialists
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
FTC reportedly to sue three largest pharmacy benefit managers
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
Proposed Medicare Physician Fee Schedule Triggers Provider Concerns
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
Loper Bright and the 340B Statute
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
FTC Accuses Drug Managers Of Squeezing Patients And Pharmacies
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
Opinion Medicare’s crazy payment system is creating monopolies in health care
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
Latest proposed cut—2.8%—shows need for Medicare pay reform
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
